It is unknown whether Wegovy causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as human relevance of semaglutide-induced rodent thyroid C-cell tumors has not been determined Wegovy is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
The Key Difference: Tirzepatide's Dual-Action Power While both medications are fantastic tools, there's a key difference
Let's discuss it at your next consultation References: Pinelli R, Reverdito V, Bellucci A, et al
That's what I help people do is find an authentic connection that makes sense, that you can sit down at the family meal at dinner and put the electronics down, VanAnrooy said
They are 80% as effective as the injections and have the same active ingredients as the semaglutide injections
Current recommendations remain based on experts opinions, and the evidence is rather limited